Related Experiment Video
Updated: Jan 10, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Hormone replacement therapy and serum uric acid in postmenopausal women: A cardiometabolic insight
Anna Vittoria Mattioli1, Camilla Cocchi2, Valentina Selleri3
1Department of Quality of Life Sciences, Alma Mater Studiorum University, Bologna, Italy.
Background And Aims:
Elevated serum uric acid (SUA) is an independent marker of cardiometabolic risk in postmenopausal women. Hormone replacement therapy (HRT) may influence SUA levels, though mechanisms and clinical implications remain underexplored. This study compares SUA and cardiometabolic indicators in HRT users and nonusers within a cardiovascular prevention cohort.
Methods And Results:
We conducted a cross-sectional analysis of 440 postmenopausal women attending a cardiovascular prevention clinic. Participants were stratified by HRT use (n = 109 users vs. n = 331 nonusers). Clinical, biochemical, and lifestyle data were collected. SUA and lipid profiles were compared using t-tests with significance set at p < 0.05. HRT users had significantly lower SUA (5.4 ± 0.27 mg/dL) versus nonusers (6.6 ± 0.24 mg/dL, p < 0.001), along with reduced LDL cholesterol, BMI, and waist circumference. No renal function differences were observed.
Conclusions:
HRT use is associated with lower SUA and more favorable cardiometabolic profiles in postmenopausal women. HRT may play a protective metabolic role and could support tailored cardiometabolic prevention in postmenopausal women.
Related Concept Videos
Atherosclerosis III: Management
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure V: Medical Management
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
Rheumatic Heart Disease III: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

